Question 1

What is the catalog number for ZNF814 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)?

Accepted Answer

The catalog number for ZNF814 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) is 51858111.

Question 2

What sizes are available for ZNF814 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)?

Accepted Answer

ZNF814 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) is available in the following size(s): 3x 1.0 µg.

Question 3

Is ZNF814 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) in stock?

Accepted Answer

ZNF814 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 5

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

ZNF814 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

Product Specifications

Gene Name

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Anti-PTGDS Antibody Picoband®

Anti-IRS1 Antibody Picoband® (Carrier-free Conjugate)

Cytokeratin 8/18 (K8.8 + DC10), CF568 conjugate, 0.1mg/mL

Uroplakin 1A (Urothelial Differentiation Marker) (UPK1A/2923), 0.2mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (rAKT1/2491), CF740 conjugate, 0.1mg/mL

CD66 (CEA) (C66/1030), Biotin conjugate, 0.1mg/mL